CONCLUSION: Our study establishes a systematic framework bridging unbiased translatome discovery to functional validation, in which we identified and functionally validated the therapeutic vulnerability of translationally activated TNFR2 in CRC. Here, TNFRSF1B is linked to colorectal carcinoma.